Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 73(7): e1601-e1610, 2021 10 05.
Article in English | MEDLINE | ID: mdl-32970811

ABSTRACT

BACKGROUND: We determined whether an audit on the adherence to guidelines for hospital-acquired pneumonia (HAP) can improve the outcomes of patients in intensive care units (ICUs). METHODS: This study was conducted at 35 ICUs in 30 hospitals. We included consecutive, adult patients hospitalized in ICUs for 3 days or more. After a 3-month baseline period followed by the dissemination of recommendations, an audit on the compliance to recommendations (audit period) was followed by a 3-month cluster-randomized trial. We randomly assigned ICUs to either receive audit and feedback (intervention group) or participate in a national registry (control group). The primary outcome was the duration of ICU stay. RESULTS: Among 1856 patients enrolled, 602, 669, and 585 were recruited in the baseline, audit, and intervention periods, respectively. The composite measures of compliance were 47% (interquartile range [IQR], 38-56%) in the intervention group and 42% (IQR, 25-53%) in the control group (P = .001). As compared to the baseline period, the ICU lengths of stay were reduced by 3.2 days in the intervention period (P = .07) and by 2.8 days in the control period (P = .02). The durations of ICU stay were 7 days (IQR, 5-14 days) in the control group and 9 days (IQR, 5-20 days) in the intervention group (P = .10). After adjustment for unbalanced baseline characteristics, the hazard ratio for being discharged alive from the ICU in the control group was 1.17 (95% confidence interval, .69-2.01; P = .10). CONCLUSIONS: The publication of French guidelines for HAP was associated with a reduction of the ICU length of stay. However, the realization of an audit to improve their application did not further improve outcomes. CLINICAL TRIALS REGISTRATION: NCT03348579.


Subject(s)
Healthcare-Associated Pneumonia , Intensive Care Units , Adult , Critical Care , Hospitals , Humans , Length of Stay
2.
Anesthesiology ; 111(2): 366-71, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19602965

ABSTRACT

BACKGROUND: Growing evidence suggests that the microvascular dysfunction is the key element of the pathogenesis of septic shock. This study's purpose was to explore whether the outcome of septic shock patients after early resuscitation using early goal-directed therapy is related to their muscle tissue oxygenation. METHODS: Tissue oxygen saturation (Sto2) was monitored in septic shock patients using a tissue spectrometer (InSpectra Model 325; Hutchinson Technology, Hutchinson, MN). For the purpose of this retrospective study, the Sto2 values were collected at the first measurement done after the macrohemodynamic variables (mean arterial pressure, urine output, central venous saturation in oxygen) were optimized. RESULTS: After the hemodynamic variables were corrected, no difference was observed between the nonsurvivors and survivors, with the exception of pulse oximetry saturation (94% [92-97%] vs. 97% [94-99%], P = 0.04). The Sto2 values were significantly lower in the nonsurvivors than in the survivors (73% [68-82%] vs. 84% [81-90%], P = 0.02). No correlations were found between the Sto2 and Spo2 (P = 0.7). CONCLUSIONS: In septic shock patients, tissue oxygen saturation below 78% is associated with increased mortality at day 28. Further investigations are required to determine whether the correction of an impaired level of tissue oxygen saturation may improve the outcome of these patients.


Subject(s)
Oxygen Consumption/physiology , Shock, Septic/metabolism , Shock, Septic/mortality , Adult , Aged , Capillaries/pathology , Carbon Dioxide/blood , Cohort Studies , Creatinine/blood , Female , Hemodynamics/physiology , Humans , Intensive Care Units , Male , Middle Aged , Muscle, Skeletal/metabolism , Oximetry , Oxygen/blood , ROC Curve , Resuscitation , Retrospective Studies , Shock, Septic/physiopathology , Spectroscopy, Near-Infrared , Survival Analysis , Survivors
3.
Middle East J Anaesthesiol ; 20(2): 277-80, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19583078

ABSTRACT

BACKGROUND: Infantile hypertrophic pyloric stenosis (IHPS) associated with metabolic alkalosis, could induce late anesthesia recovery, especially when opioids are used. The aim of this study was to compare the time of extubation and the quality of perioperative analgesia in infants scheduled for pyloromyotomy, receiving either isoflurane inhalation or remifentanil infusion. METHODS: Thirty full-term infants scheduled for pyloromyotomy were prospectively studied. A standardized anesthetic induction was performed. For maintenance of anesthesia, infants were randomly allocated to receive either isoflurane 0.75% of inspired concentration (GI n = 15), or remifentanil as a continuous infusion of 0.4 microg x kg(-1) x mn(-1) (GR n = 15). At the beginning of skin closure, the anesthetic was discontinued and 15 mg x kg(-1) of paracetamol administered. Non parametric tests were used in statistical analysis. RESULTS: The time to extubation was similar in both groups. The intraoperative heart rate was significantly lower in the GR group. CONCLUSION: Remifentanil provided better intraoperative analgesia than isoflurane in infants undergoing pyloromyotomy without increasing time to extubation.


Subject(s)
Anesthetics, Intravenous/therapeutic use , Isoflurane/therapeutic use , Piperidines/therapeutic use , Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Anesthetics, Inhalation/therapeutic use , Female , Heart Rate/drug effects , Humans , Infant , Infant, Newborn , Intubation, Intratracheal , Male , Perioperative Care , Prospective Studies , Pyloric Stenosis, Hypertrophic/surgery , Remifentanil , Single-Blind Method , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...